Latest in Finished Product

New UK-developed blood test identifies breast cancer type without biopsy

A new ctDNA-based blood test offers near-90% accuracy in identifying and tracking breast cancer subtypes, opening opportunities for earlier treatment matching and more efficient therapy selection

Find out more

Grace and Molecule.One join forces to transform peptide building block synthesis with AI

The pair have entered into a multi-year strategic agreement to accelerate drug development timelines, strengthen US manufacturing capabilities and help bring lifesaving...
See more

Broughton launches ISO/IEC 17025-accredited methods for accurate cannabinoid analysis in oils and tinctures

Broughton has introduced accredited HPLC-MS/MS methods to reliably quantify cannabinoids — including Total THC and Total CBD — in oils, tinctures and selected e-liquids, providing robust data for formulation, batch verification and regulatory compliance

SGS achieves breakthrough in infectious disease research with launch of novel RSV A-strain

Derived from a 2015 circulating strain, SGS's novel RSV-A challenge agent offers a closer match to circulating RSV viruses than strains currently used in clinical research

Polpharma Biologics announces US launch of Tyruko, the first FDA-approved natalizumab biosimilar for MS

Tyruko is now available to US patients with multiple sclerosis and Crohn’s disease, expanding access to a more affordable biologic option

Fresenius Kabi recalls three lots of Famotidine Injection due to elevated endotoxin levels

Fresenius Kabi has issued a voluntary recall of three US lots of its Famotidine Injection, USP, after out-of-specification endotoxin results were found in reserve samples

Bavarian Nordic launches chikungunya vaccine Vimkunya in the UK

The UK announcement of the recombinant vaccine follows recent approval by the MHRA in May 2025

Mastering the art of oral solid dosage manufacturing: join our FREE webinar

Tackle the challenges you're facing in oral solid dosage (OSD) manufacturing

Pharmaceutical company Avency launches with focus on supply chain resiliency

The US-based pharmaceutical production firm has launched to pursue 25+ new products over next two years, with a differentiated business model to ensure supply chain resiliency through an established manufacturing partner network

Aseptic spray drying: Transforming biotherapeutics for a new era

With interest in aseptic spray drying on the rise in the pharmaceutical industry, Dr Kevin Robinson spoke to GEA’s David Costes about how the company is combining process, engineering and technological expertise with market insights to provide a safe, reliable and high-performance technology for advanced biotherapeutic powder applications

Sponsor content

BOLA product highlight flyer available now - Professional high-performance fluoroplastic labware

BOLA produces a range of sophisticated, professional laboratory products constructed from high-performance materials, developed and manufactured by in-house specialists...

GELITA to showcase next-gen collagen excipients at COMPAMED 2025

Designed for sensitive applications such as vaccines, wound care, tissue engineering and 3D bioprinting, the company’s Endotoxin Controlled Excipients portfolio sets new...

Vetter once again named best managed company

The award jury recognises strategic and sustainable corporate management

New Domino Mx-Series labelling machines

Domino’s new print and apply labellers automate traceability coding for enhanced supply chain visibility